Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes...
主要な著者: | Gloyn, A, Faber, J, Malmodin, D, Thanabalasingham, G, Lam, F, Ueland, P, McCarthy, M, Owen, K, Baunsgaard, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Public Library of Science
2012
|
類似資料
-
Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
著者:: Anna L Gloyn, 等
出版事項: (2012-01-01) -
Diagnosis and management of maturity onset diabetes of the young (MODY).
著者:: Thanabalasingham, G, 等
出版事項: (2011) -
Diagnosis and management of maturity onset diabetes of the young (MODY).
著者:: Thanabalasingham, G, 等
出版事項: (2011) -
Diagnosis and management of maturity onset diabetes of the young (MODY)
著者:: Thanabalasingham, G, 等
出版事項: (2011) -
Mature onset diabetes of the young (MODY).
著者:: E Lacerda Nobre, 等
出版事項: (2002-12-01)